Patient-level factors associated with hemoglobin A1C testing in Alabama Medicaid beneficiaries with diabetes.

Publisher: Elsevier Country of Publication: England NLM ID: 101463825 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0210 (Electronic) Linking ISSN: 18780210 NLM ISO Abbreviation: Prim Care Diabetes Subsets: MEDLINE

Original Publication: Kidlington, Oxford : Elsevier

Medicaid* ; Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/therapy; Adult ; United States/epidemiology ; Humans ; Female ; Glycated Hemoglobin ; Retrospective Studies ; Alabama/epidemiology

Aim: We evaluated patient-level factors associated with receipt of hemoglobin A1c (HbA1c) testing among Alabama Medicaid beneficiaries with type 2 diabetes.
Methods: We conducted a retrospective analysis of person-year observations from Medicaid claims data from 2011 to 2020. Adults aged 19-64 years with type 2 diabetes and continuous enrollment in Medicaid for study year and year prior were included. Primary outcomes were ≥ 1 and ≥ 2 HbA1c test(s) per year. We conducted multivariable Poisson regression stratified by Medicaid eligibility reason (disability, poverty) examining the association of study year, demographics, clinical factors, and healthcare utilization with HbA1c testing.
Results: We analyzed 288,379 observations, 51% with disability-based, 49% poverty-based eligibility. Overall, 57% observations had ≥ 1 HbA1c, 35% had ≥ 2 HbA1c tests. More observations with disability-based than poverty-based eligibility had ≥ 1 (76% vs. 38%) and ≥ 2 HbA1c tests (49% vs. 20%). Patient-level factors were associated with a higher likelihood of having ≥ 1 HbA1c: Black race and older age (disability-based eligibility); year after 2011, female sex, and younger age (poverty-based eligibility); and rurality, insulin use, endocrinology care, diabetes complications, and ambulatory care visits (both groups).
Conclusions: Just over one-third of adult Alabama Medicaid beneficiaries with diabetes had ≥ 2 HbA1c tests per year; testing frequency differed by Medicaid eligibility.
(Copyright © 2023 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.)

Diabetes Care. 2019 Jan;42(Suppl 1):S46-S60. (PMID: 30559231)
Diabetes Care. 2019 Mar;42(3):416-426. (PMID: 30104301)
JAMA. 2017 Aug 22;318(8):695-696. (PMID: 28715569)
J Gen Intern Med. 2021 Dec;36(12):3665-3671. (PMID: 34545472)
Curr Med Res Opin. 2021 Nov;37(11):1859-1866. (PMID: 34402701)
Diabetes Care. 2014 Apr;37(4):993-1001. (PMID: 24255103)
Popul Health Manag. 2020 Jun;23(3):256-263. (PMID: 31513472)
BMC Endocr Disord. 2014 Oct 09;14:82. (PMID: 25298071)
J Am Board Fam Pract. 2005 Jul-Aug;18(4):262-70. (PMID: 15994472)
Am J Public Health. 2001 Jan;91(1):76-83. (PMID: 11189829)
Endocr Pract. 2000 Sep-Oct;6(5):361-6. (PMID: 11141586)
Diabetes Care. 2004 May;27(5):1060-5. (PMID: 15111521)
Diabetes Care. 2016 Jul;39(7):1208-17. (PMID: 27330127)
JAMA Intern Med. 2019 Oct 01;179(10):1376-1385. (PMID: 31403657)
J R Soc Med. 2021 Jun;114(6):299-312. (PMID: 33821695)
Health Serv Res. 2020 Oct;55(5):741-772. (PMID: 32720345)
Diabetes Care. 2017 Oct;40(10):1409-1419. (PMID: 28754780)
Lancet. 2012 Jun 16;379(9833):2252-61. (PMID: 22683130)
Diabetes Care. 2020 Nov 2;:. (PMID: 33139407)
Med Care. 2020 Jun;58(6):549-556. (PMID: 32028524)
BMJ. 2000 Aug 12;321(7258):405-12. (PMID: 10938048)
Diabetes Care. 2018 May;41(5):917-928. (PMID: 29567642)
Am J Public Health. 2016 Jan;106(1):63-9. (PMID: 26562119)
Diabetes Care. 2014 Sep;37(9):2565-71. (PMID: 24947789)
J Clin Epidemiol. 2004 Dec;57(12):1288-94. (PMID: 15617955)

K23 AT011375 United States AT NCCIH NIH HHS; P30 DK079626 United States DK NIDDK NIH HHS; R18 DK109501 United States DK NIDDK NIH HHS

Keywords: Hemoglobin A1c Measurement; Low-income; Medicaid; Population Health; Type 2 Diabetes

0 (Glycated Hemoglobin)

Date Created: 20231020 Date Completed: 20231216 Latest Revision: 20240420

20240420

PMC10841383

10.1016/j.pcd.2023.10.002

37858401